Apotex gets FDA ultimatum; Teva recalls propofol

> Apotex got an ultimatum from the FDA: Fix your manufacturing problems, or forget introducing new meds in the U.S. Report

> Teva, maker of the anesthetic propofol, has a massive recall underway following dozens of patients getting sick from two batches. Bacterial contamination is the chief suspect. Article

> EMCOR will provide facilities and energy management services for Patheon at the contract manufacturer's three U.S. plants in Manati and Caguas, Puerto Rico, and Cincinnati. Release

> A groundbreaking ceremony took place recently for a planned 200,000-square-foot, $30-million Viva Biopharm manufacturing plant in Blaine, WA. Article

> The Pharmaceutical Council of Nigeria cites an increasing rate of fake pharmaceutical products in circulation, and attributed the trend to the failure of manufacturers to conform to standards. Article

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.